dvm360

First treatment for delaying canine congestive heart failure receives FDA approval

The approval broadens Vetmedin’s label, which already covers management of mild to severe congestive heart failure in dogs with clinical myxomatous mitral valve disease or dilated cardiomyopathy.

FDA approves first drug to delay the onset of congestive heart failure in dogs

The MarketWatch News Department was not involved in the creation of this content.-- Heart disease affects approximately 10 percent of dogs in their lifetime1 -- VETMEDIN(R) (pimob ...
Medindia

FDA Approves First Preventive Heart Failure Drug for Dogs

Discover how the FDA's approval of Vetmedin, the first drug to delay congestive heart failure in dogs, is transforming canine ...
Nature

Canine Mitral Valve Disease And Heart Failure

Canine mitral valve disease, most commonly stemming from myxomatous degeneration, is the predominant acquired cardiac condition in dogs. This disease is characterised by progressive deterioration of ...
dvm360

Wrap up: FDA approves treatment for delaying canine congestive heart failure, and other news

The American College of Veterinary Anesthesia and Analgesia’s (ACVAA) board of directors approved the ACVAA Fellowship in Pain Management. The new fellowship is for individuals and programs that have ...

US FDA approves first drug to delay heart failure in dogs

Jan 19 (Reuters) - Pharmaceutical company Boehringer Ingelheim said on Monday the U.S. Food and Drug Administration had ...